Australian designed & manufactured

Comprehensive health screening in 15 minutes.
Anywhere.

The EVEDA HubX captures 300+ diagnostic data points across six vital organs using just five drops of blood and a urine sample. No venepuncture. No lab. No waiting.

ARTG listed, Class IIb device Medsafe registered (NZ) ISO 13485 certified Randox & RCPA-QAP validated
EVEDA HubX portable diagnostic device
300+
Diagnostic parameters
6
Vital organs screened
~90%
Cost reduction
15min
Sample to results
Solutions

Built for your world

Whether you're screening employees on a mine site, equipping a remote clinic in the Pacific, or distributing diagnostics across a country. EVEDA adapts.

The EVEDA ecosystem

Five integrated layers of healthcare infrastructure

EVEDA is not a device. It is a complete healthcare platform: hardware, clinical software, patient engagement, practice management, and population health analytics, connected end to end.

Capture

HubX device

Portable point-of-care screening captures 300+ data points across six vital organs in 15 minutes. Five drops of blood, no venepuncture, no lab.

Manage

Clinical suite, OpX

Patient management, telehealth, appointment scheduling, billing, and clinical workflows, all in one platform for GPs and health services.

Engage

Health Passport app

Patients own their health data. View results, track trends, share with their GP, manage prescriptions, and access diet and fitness modules.

Learn

DAX analytics

De-identified, aggregated population insights. Health risk scoring, demographic trends, disease progression tracking, and longitudinal health dashboards.

The EVEDA advantage

Comprehensive screening at ~90% less than traditional pathology

Traditional corporate health screening requires venepuncture, external pathology labs, multiple appointments, and weeks of waiting. EVEDA delivers more tests, faster, onsite, at a fraction of the cost.

Calculate your savings
Point-of-care blood sample testing
Traditional
EVEDA HubX
Tests per screening
10–20
300+
Time to results
3–7 days
15 minutes
Venepuncture
Yes
No
Lab required
Yes
No
Specialist operator
Yes
No
Organs screened
1–2
6 vital organs
Validated & certified

Independently verified to clinical standards

EVEDA's diagnostic accuracy is validated by leading international and Australian pathology quality programs. Our systems are certified to medical device, information security, and quality management standards.

Regulatory

TGA, ARTG listed

Class IIb medical device system (ARTG 346638) and Class I clinical software (ARTG 342561) on the Australian Register of Therapeutic Goods

Independent validation

Randox validated

Diagnostic accuracy independently verified using Randox international quality controls, the global benchmark for clinical laboratory performance

Independent validation

RCPA-QAP program

Validated through the Royal College of Pathologists of Australasia Quality Assurance Program, the standard used by every major pathology lab in AU and NZ

Regulatory

Medsafe (New Zealand)

Registered with New Zealand's medicines and medical devices safety authority for Oceania-wide deployment

Certified

ISO 13485 & ISO 9001

Medical device quality management system and general quality management certified to international standards

Certified

ISO 27001

Information security management system certified, protecting patient health data across cloud infrastructure

View evidence & compliance
How it works

From sample to insight in four steps

1

Collect

Five drops of capillary blood and a urine sample. No needles, no venepuncture. Under 2 minutes.

2

Analyse

HubX processes 300+ data points across brain, heart, kidney, liver, lungs, and pancreas simultaneously.

3

Report

Results appear in the Health Passport app within 15 minutes, accessible on any smartphone, shareable with your GP.

4

Act

Health risk alerts and comorbidity insights guide immediate clinical decisions. Telehealth integration for remote review.

Designed for impact

From screening to measurable outcomes

EVEDA's integrated platform is designed to shift healthcare from reactive treatment to proactive prevention, delivering clinical and operational value across every deployment setting.

Earlier risk identification

Screening six vital organs simultaneously, brain, heart, kidney, liver, lungs, and pancreas, enables detection of chronic disease risk factors before symptoms present.

Supported by comprehensive multi-parameter screening methodology

Reduced diagnostic delays

Results available in 15 minutes onsite, eliminating the 3–7 day wait for external pathology labs and enabling same-day clinical decisions and referrals.

Based on HubX operational performance vs traditional pathology turnaround

Workforce productivity

Onsite screening removes the need for employees to attend external appointments, reducing absenteeism associated with health assessments and follow-up visits.

Designed to reduce screening-related absenteeism in corporate deployments

Screening access in remote areas

At 5.6kg with standalone power and satellite connectivity, HubX brings comprehensive screening to communities that would otherwise require costly patient transport to regional centres.

Purpose-built for remote, rural, and community health settings

Reduced avoidable hospitalisations

Regular comprehensive screening supports early intervention for chronic conditions, helping to prevent complications that lead to emergency presentations and hospital admissions.

Designed to support preventive care pathways aligned to chronic disease frameworks

Population health insights

De-identified, aggregated analytics through DAX enable organisations and health services to identify trends, target interventions, and measure program effectiveness at population scale.

Available through de-identified DAX analytics module
Real-world deployments

Proven in the field

EVEDA has been deployed across corporate, community, and remote health settings. Detailed case data is available under NDA for qualified evaluators.

Corporate office environment Corporate health

Workforce screening, primary industries

A large-scale onsite screening program deployed across multiple sites in the Australian primary industries sector, delivering comprehensive health assessments to employees working in challenging environments.

4Weeks
300+Tests per person
0Lab dependency
Remote Australian landscape Remote & community

Community health screening, remote Australia

Portable deployment to remote and regional communities where geography creates fundamental barriers to accessing traditional primary care and pathology services.

15Min per screen
6Organs assessed
1Operator needed
Request detailed case data (NDA)
Sectors

One device, every setting

From a corporate office in Sydney to a remote atoll in the Pacific. HubX delivers the same comprehensive diagnostic capability.

Corporate health Mining & resources Indigenous health Aged care Defence Rural & remote Primary care Pacific Islands Community pharmacy Emergency services
Why EVEDA exists

Our founder lost three close friends to undetected chronic conditions. They had access to one of the world's best healthcare systems. The system was not looking.

EVEDA was built to change that. Not to replace the healthcare system, but to fill the structural gap that leaves chronic disease undetected until it becomes an emergency.

Read the full story
Advisory board

Guided by Australia's health leaders

Zack Baala

Mr Zack Baala

CEO, Founder, Board Member
Colin Kofoed

Mr Colin Kofoed

Board Member, Executive Director
Prof. Ngiare Brown

Prof. Ngiare Brown

Advisory Board Member
Toby Ralph

Mr Toby Ralph

Advisory Board Member
The Hon. Philip Dalidakis

Hon. Philip Dalidakis

Advisory Board Member
David Mazzeo

Mr David Mazzeo

Advisory Board Member
Dr. Robert Irlicht

Dr Robert Irlicht

Advisory Board Member
Ines Petkovic

Ms Ines Petkovic

Advisory Board Member
Jack Cook

Jack Cook

Advisory Board Member

Ready to transform your health screening?

Whether you're screening 50 employees or equipping a network of remote clinics, we'll show you exactly how EVEDA fits your operation.